Tag Archives: WuXi Genome Center

SAN DIEGO & SHANGHAI–(BUSINESS WIRE)–March 10, 2014–Illumina, Inc. (NASDAQ:ILMN) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company with operations in China and the United States, today announced that the WuXi Genome Center ...

Read More »